Glutamate receptor ionotropic NMDA subunit 2A (GluN2A) (GluN2A)

The Glutamate receptor ionotropic NMDA subunit 2A (GluN2A), encoded by the GRIN2A gene, is a critical component of the N-methyl-D-aspartate (NMDA) receptor complex, a ligand-gated ion channel essential for excitatory neurotransmission in the brain [1, 3]. NMDA receptors are heterotetramers typically composed of two GluN1 subunits and two GluN2 subunits; the GluN2A subunit specifically contains the orthosteric binding site for the primary excitatory neurotransmitter, glutamate [2, 4]. This glutamate binding site is located within the extracellular ligand-binding domain (LBD) formed by the S1 and S2 segments of the protein [4]. Activation of this site, alongside the glycine site on GluN1, triggers a conformational change that opens the ion channel pore, allowing the influx of calcium and sodium ions [4, 5]. This process is fundamental to synaptic plasticity, long-term potentiation (LTP), and cognitive functions such as learning and memory. Dysregulation or mutations in the GluN2A subunit are linked to various neurological conditions, including epilepsy-aphasia spectrum disorders, schizophrenia, and neurodegenerative diseases [3, 5]. Pharmacological targeting of the GluN2A glutamate site or its allosteric sites aims to modulate excitatory signaling, with research focusing on both competitive antagonists for neuroprotection and positive allosteric modulators for cognitive enhancement [2, 4].

Other names

GRIN2ANMDAR2ANR2AGlutamate [NMDA] receptor subunit epsilon-1NMDA receptor subunit 2AhNR2A

Competitive antagonism at the orthosteric glutamate binding site, uncompetitive channel blockade, or allosteric modulation of the NMDA receptor complex to regulate calcium-permeable ion flow.